IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Design and Development of Indian Propolis Loaded Poly (e -Caprolactone) Nanoparticles For Improved Anticancer Efficacy

Author: DR. SATHIYANARAYANAN LOHIDASAN, HARSHAD KAPARE , ARULMOZHI S , KAKASAHEB MAHADIK
Abstract: Propolis, a natural product obtained from apiculture and is well proven for its anticancer potential. Anticancer efficacy of propolis is limited to its poor water solubility and bioavailability. The present study was designed and investigated for development of ethanolic extract of Indian propolis (EEIP) loaded Poly (e-caprolactone) nanoparticles (EPL) to achieve improved solubility, sustained drug release and enhanced cytotoxic efficacy of EEIP. Formulation development, characterization and optimization were carried out by design of experiment approach. Developed formulations were evaluated in detail for nanoparticle characterization and in vitro cytotoxicity study. Developed nanoparticles showed particle size, and encapsulation efficiency of 190 ± 1 - 230 ± 2 nm and 62.66± 1.20 - 67.18± 1.80 % respectively. Optimized formulation EPL showed sustained drug release over a period of 48 h. Concentration of the drug needed for total growth inhibition of cells in a designed time period (TGI) was decreased by 33.06% for EPL as compared to EEIP in human breast cancer MCF-7 cells and 22.31% in human colon cancer cells HT-29 indicating improved cytotoxicity of EEIP. The study proven that the optimized EPL exhibited increased solubility, sustained drug release and enhanced in vitro cytotoxicity on MCF-7 and HT-29 cell lines in comparison with EEIP. Thus developed system may be served as potential nanocarrier in anticancer treatment.
Keyword: Indian propolis; Poly (e-caprolactone); Design of experiment; Sulforhodamine B (SRB) assay
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events

CiteScore 2016 -  0.09

SJR 2016 - 0.111

SNIP 2016 - 0.055

Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)